Tags » Sorafenib

Three New Lung Cancer Genetic Bio Markers Identified

SNPs (single-nucleotide polymorphisms) are variations in our DNA that determine our susceptibility to developing some diseases. Using the largest genome-wide SNP-smoking interaction analysis reported for lung cancer, a research team has identified three novel SNPs. 40 more words

Apple Pharmaceuticals

Сорафенат 200 мг таблетка - Использование, побочные эффекты, меры предосторожности | Купить Sorafenib Online в Apple Pharmaceuticals

Sorafenat

Сорафенат 200 мг таблетка (сорафениб) – это бренд Natco, который является общей версией Nexavar. Сорафенат-таблетка содержит Сорафениб в качестве активного ингредиента. Это ингибитор пероральной киназы, используемый для лечения рака почек и печени. 18 more words

Anti Cancer Medicine

Sorafenat 200mg Tablet – Uses, Side-Effects, Precautions | Buy Sorafenib Online

Sorafenat

Sorafenat 200mg tablet (sorafenib) is a brand of Natco that is a generic version of Nexavar. Sorafenat Tablet contains Sorafenib as an active ingredient. It is an oral kinase inhibitor used for kidney and liver cancer. 148 more words

Apple Pharmaceuticals

Liver Food

What happens when you were told that you have a terminal disease in your liver and you are counting your days. This happened just a few days back to my dad who was living a healthy life. 663 more words

India

NEXAVAR : #Nexavar 200 mg Tablets , #Sorafenib 200mg Wholesale Price Supply Roche India


Get Nexavar 200mg Having Sorafenib Tablets Wholesale Price Supplier, Manufactured by Roche, Get Nexavar Price, Side effects, Uses, Side effects, Sorafenib treat liver cancer, thyroid cancer, or a type of kidney cancer called advanced renal cell carcinoma. 54 more words

NEXAVAR : #Nexavar 200 mg Tablets , #Sorafenib 200mg Wholesale Price Supply Roche India


Get Nexavar 200mg Having Sorafenib Tablets Wholesale Price Supplier, Manufactured by Roche, Get Nexavar Price, Side effects, Uses, Side effects, Sorafenib treat liver cancer, thyroid cancer, or a type of kidney cancer called advanced renal cell carcinoma. 54 more words

Article by Disease – Inhibition of the VEGF/VEGFR Pathway Improves Survival in Advanced Kidney Cancer – Current Drug Targets

ARTICLE BY DISEASE ON “KIDNEY CANCER”

Abstract:

Despite the improvement in progression-free survival and response rates, none of the five anti- VEGF/VEGFR agents used for treatment of metastatic renal cell carcinoma (mRCC) reported a significant increase in patients’ survival. 175 more words

Bentham Science Publishers